Hemab Therapeutics Holdings Inc (COAG) Stock Analysis
Verdict: HOLD
Aggressive insider buying and a niche coagulation pipeline drive momentum, but current price parity with analyst targets limits near-term upside.
Investment score: 64/100
Analysis as of
Is Hemab Therapeutics Holdings Inc stock worth reviewing? AI model thesis
Hemab is a high-conviction biotech play with significant institutional backing, but technical overextension suggests caution for new entries at $49.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 55/100 (weight 15%)
- Technical Momentum: 85/100 (weight 15%)
- Earnings Quality: 40/100 (weight 15%)
- Insider Sentiment: 95/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 70/100 (weight 15%)
Hemab Therapeutics Holdings Inc opportunities and risks
What speaks for COAG
- Deep Institutional Floor
What speaks against COAG
- Negative Equity and Balance Sheet Insolvency
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| COAG | n/a | 0.0x | n/a | 0.0% | 0.0% | -62.0% |
| MLYS | n/a | 0.0x | n/a | 0.0% | 0.0% | -7.7% |
| VCEL | 106.9x | 8.0x | 66.0x | 74.8% | 7.3% | 2.5% |
| SLS | n/a | 0.0x | n/a | 0.0% | 0.0% | -1.2% |
| KLRA | n/a | 0.0x | n/a | 0.0% | 0.0% | -5.3% |
| BCRX | n/a | 2.2x | n/a | 18.9% | -51.7% | 15.4% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -1.2% |
Frequently asked questions about Hemab Therapeutics Holdings Inc (COAG)
Is COAG stock a good investment?
The cached TradeMates AI model rates Hemab Therapeutics Holdings Inc as HOLD with an investment score of 64/100. Hemab is a high-conviction biotech play with significant institutional backing, but technical overextension suggests caution for new entries at $49. This is algorithmic model output, not personal investment advice.
Is COAG stock a buy?
The TradeMates model verdict for COAG is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.